These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4431240)

  • 1. Comparative studies on the influence of Provasan, Complamine, Sadamine, A-100 and Clofibrat on the behaviour of some lipid fractions of plasma in experimental animals.
    Sulowska Z
    Mater Med Pol; 1974; 6(2):102-6. PubMed ID: 4431240
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of amino acid derivative of clofibric acid (WKLB-5), and theophylline monoester of nicotinic acid (ME1) on the development of experimental atherosclerosis in rabbits.
    Wójcicki J; Jaworska M; Samochowiec L; Hinek A
    Pol J Pharmacol Pharm; 1986; 38(1):77-84. PubMed ID: 3509959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of Clofibrat on plasma lipid levels.
    Szostak WB; Cybulska B; Ruzyllo E
    Mater Med Pol; 1971; 3(4):12-4. PubMed ID: 5162168
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preliminary study of the effects of nicotinic-N-oxide acid causing hypolipidemia administered alone or in combination with clofibrate].
    Palamara G; De Luca G; Materazzi M
    Boll Chim Farm; 1977 Oct; 116(10):596-600. PubMed ID: 607948
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypolipidemic effect of the new diprophylline derivative, [2-hydroxy-3-(theophylline-7-ol] propyl ester of 4-benzylhydroxybenzoic acid].
    Ryzhenkov VE; Chistiakova AM; Wójcicki J; Samochowiec L; Daday R
    Vopr Med Khim; 1988; 34(4):109-12. PubMed ID: 3195124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on some pharmacologic properties of a new ester of the nicotinic acid: mesoinositol-pentanicotinate.
    Linari G
    Arzneimittelforschung; 1972 Aug; 22(8):1419-21. PubMed ID: 4678404
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
    Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
    Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
    Maroto ML; Priego JG; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of pregnancy and insulin administration on plasma lipid levels in the rabbit.
    Acebal C; Arche R; Castro J; Municio AM
    Steroids Lipids Res; 1973; 4(5):310-22. PubMed ID: 4794918
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of clofibrate on aortic glycosamine-glycans and proteins and on serum lipid levels in experimental atherosclerosis.
    Bihari-Varga M; Fehér J; Varsányi M; Gerö S
    Acta Med Acad Sci Hung; 1973; 29(3):217-29. PubMed ID: 4270563
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood-aqueous barrier changes during activation of fibrinolysis in plasma].
    Rudobielski R
    Klin Oczna; 1974 Feb; 44(2):129-33. PubMed ID: 4453093
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative studies on the effect of commercial lipid-lowering substances on the lipolysis of isolated rat and human fat cells].
    Ditschuneit HH; Fussgänger R; Ditschuneit H
    Verh Dtsch Ges Inn Med; 1978; (84):1155-7. PubMed ID: 741914
    [No Abstract]   [Full Text] [Related]  

  • 13. [New viewpoints in therapy using vasoactive drugs].
    Gloor M
    Med Welt; 1974 Sep; 25(36):1433-5. PubMed ID: 4612288
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study on the modification of oxygen consumption of rat liver and brain homogenates by xanthinol nicotinate and nicotinic acid].
    Brenner G
    Arzneimittelforschung; 1974 Mar; 24(3):321-5. PubMed ID: 4407877
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of Xantinol nicotinate (Complamina) in experimental pulmonary fibrin embolism.
    Boruah KD; Chakravarti RN; Wahi PL
    Indian J Med Res; 1974 Jun; 62(6):923-9. PubMed ID: 4435907
    [No Abstract]   [Full Text] [Related]  

  • 16. [Plasma and aorta fatty acids during nutritional atheroma in rabbits. I. The fatty acids of the lipid fractions of plasma].
    Warembourg H; Bertrand M; Biserte G; Sezille G
    Rev Fr Etud Clin Biol; 1966; 11(7):719-22. PubMed ID: 5971599
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of vitamin A (retinol), Tioadenolo and a standard diet on the plasma lipid pattern in the rat on an atherogenic diet].
    Carbini L; Dazzi E; Lantini T; Peretti Padalino A; Seu A
    Boll Soc Ital Biol Sper; 1984 Aug; 60(8):1527-33. PubMed ID: 6497988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intra-arterial and intravenous Complamine therapy].
    Musil HE
    Med Welt; 1973 Nov; 24(45):1759-61. PubMed ID: 4768209
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and experimental study of modifications in plasma lipids induced by alcohol].
    Jaillard J; Sezille G; Scherrereel P; Fruchart JC
    Nutr Metab; 1971; 13(2):114-27. PubMed ID: 5123768
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulation of anti-aggregatory activity from rat aorta by hypolipidemic drugs.
    Weithmann KU; Granzer E
    Artery; 1980; 8(5):475-81. PubMed ID: 7011266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.